Cite
HARVARD Citation
Marabelle, A. et al. (2022). Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study. Lancet gastroenterology and hepatology. pp. 446-454. [Online].